ABCL

#1697
AbCellera Biologics Inc. - Common Shares
6.1 8 USD
+7.85%
Setor: Cuidados de saúde
Base: USD
Moeda do lucro: USD
Faixa diária
6.05
6.22
Faixa anual
1.98
6.52
Mudança diária
+7.85%
Mudança mensal
+59.28%
Mudança em 6 meses
+71.19%
Mudança anual
+202.94%
Fechamento anterior
5.7 3
Open
6.0 6
Mínimo
6.0 5
High
6.2 2
Volume
1 579
Abrir gráfico completo Full chart

Financials

Visão geral Relatórios Estatísticas
Trimestral Ano
Demonstração de resultados Balanço patrimonial Fluxo de caixa
Valor Q4, 24Q1, 25Q2, 25Q3, 25Q4, 25Q1, 26 TTM

AbCellera Biologics Inc. - Common Shares

AbCellera Biologics Inc. is a Vancouver, British Columbia-based biotechnology company that discovers and develops antibody therapeutics. The company is best known for its leading role in the Pandemic Prevention Platform, a project of DARPA's Biological Technologies Office. AbCellera utilizes a proprietary technology platform, which they claim can develop "medical countermeasures within 60 days." Its platform for single-cell screening was initially developed at the University of British Columbia.

Notícias